Clinical implications of prostaglandin inhibition in the small bowel

Gastroenterology Clinics of North America

Volumn 30, Issue 4, 2001, Pages 953-970

  Houchen, Courtney W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN; ROFECOXIB;

DRUG SAFETY; DUODENUM INJURY; ENTERITIS; EXPERIMENTAL ANIMAL; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; HUMAN; INTESTINE PERFORATION; INTESTINE ULCER; NONHUMAN; PROSTAGLANDIN SYNTHESIS INHIBITION; REVIEW; SMALL INTESTINE; STOMACH INJURY;

EID: 0035198105     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(05)70222-3     Document Type: Article

References (75)

1. Small-bowel side-effects of non-steroidal anti-inflammatory drugs
2. Use of intraoperative enteroscopy to diagnose nonsteroidal anti-inflammatory drug injury to the small intestine
3. Enteroscopy with enteroclysis
4. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs
5. Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats: Physicochemical and biochemical factors involved
6. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans
7. Intestinal permeability, non-steroidal anti-inflammatory drug enteropathy and inflammatory bowel disease: An overview
8. 51Cr-EDTA test for intestinal permeability
9. Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures
10. Misoprostol reduces indomethacin-induced changes in human small intestinal permeability
11. Intestinal permeability and inflammation in rheumatoid arthritis: Effects of non-steroidal anti-inflammatory drugs
12. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs
13. Effect of non-steroidal anti-inflammatory drugs on the human small intestine
14. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans
15. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
16. Indomethacin-induced intestinal lesions in the rat
17. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized though cyclooxygenase-1
18. Diagnostic and therapeutic push type enteroscopy in clinical use
19. Eicosanoids and the gastrointestinal tract
20. Aspirin and bleeding peptic ulcers in the elderly
21. Indomethacin and recurrent ileal perforations in a preterm infant
22. Expression and selective inhibition of the constitutive and inducible forms of human cyclooxygenase
23. Prevention of NSAID-induced gastric ulcer with misoprostol: Multicentre, double-blind, placebo-controlled trial
24. Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss: Effects of sulfasalazine and other disease-modifying antirheumatic drugs
25. Nonsteroidal antiinflammatory drugs and lower gastrointestinal bleeding
26. Disruption of cyclooxygenase-1 gene results in an impaired response to radiation injury
27. Increased intestinal permeability in patients with rheumatoid arthritis: A side-effect of oral nonsteroidal anti-inflammatory drug therapy?
28. Recent insights into the structure, function and biology of cPLA2
29. Small intestinal ulcers and intestinal flora in rats given indomethacin
30. Surgical complications of nonsteroidal antiinflammatory drug-induced small bowel ulceration
31. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
32. A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis
33. Receptors for a growing family of secreted phospholipases A2
34. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding
35. Diaphragm disease: Pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs
36. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
37. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage
38. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents
39. "Diaphragm-like" strictures of the small bowel in patients treated with non-steroidal anti-inflammatory drugs
40. Small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs for rheumatoid arthritis
41. Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells
42. Cyclooxygenase-2: Regulation and relevance in inflammation
43. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
44. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs
45. Short report: The effect of misoprostol on the anaemia of NSAID enteropathy
46. Nonsteroidal anti-inflammatory drug enteropathy
47. Small bowel enteroscopy in undiagnosed gastrointestinal blood loss
48. Regulatory functions of phospholipase A2
49. Gastrointestinal perforation following indomethacin therapy in very low birth weight infants
50. Arachidonic acid metabolism
51. Recurrent small bowel obstruction associated with phenylbutazone
52. Cloning of human prostanoid receptors
53. Role of endogenous prostaglandins in preventing gastrointestinal ulceration: Induction of ulcers by antibodies to prostaglandins
54. Resistance of germfree rats to indomethacin-induced intestinal lesions
55. Diaphragm disease of the small bowel: A case without apparent nonsteroidal antiinflammatory drug use
56. Diaphragmlike strictures of the small bowel associated with use of nonsteroidal antiinflammatory drugs
57. Pancreatic phospholipase A2: Isolation of the human gene and cDNAs from porcine pancreas and human lung
58. COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: A double blind crossover study comparing rofecoxib with placebo and indomethacin
59. Intestinal permeability and inflammation in patients on NSAIDs
60. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study
61. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: A randomized, double-blind, placebo-controlled trial
62. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial
63. The influence of food and repeated dosing on the bioavailability of indomethacin from a multiple units controlled-release formulation
64. Pathogenesis of nonsteroidal anti-inflammatory drug-related upper gastrointestinal toxicity
65. Ulcers, nonsteroidal anti-inflammatory drugs, and related matters
66. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer
67. Non-steroidal anti-inflammatory agents and the gastrointestinal tract
68. Non-steroidal anti-inflammatory induced diaphragm disease of the small intestine: Complexities of diagnosis and management
69. Comparison of the intestinal toxicity of celecoxib, a selective COX-2 inhibitor, and indomethacin in the experimental rat
70. 2 gene family in mammals
71. Iron deficiency anaemia in patients with rheumatic disease receiving non-steroidal anti-inflammatory drugs: The role of upper gastrointestinal lesions
72. Misoprostol for the treatment of peptic ulcer and anti-inflammatory-drug-induced gastroduodenal ulceration
73. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat
74. Enteroscopy-enteroclysis: Experience with a combined endoscopic-radiographic technique
75. NSAID injury to the small intestine